Food-Related Attentional Biases in Restrained Eaters: A Meta-Analysis
Abstract
Objective: Dietary restraint may contribute to the development and maintenance of eating disorders (EDs), with food-related attentional biases (ABs) as a key underlying mechanism. We examined associations between dietary restraint and ABs and explored how several methodological factors (i.e., AB mechanism, mode of AB investigation, response task type, stimulus task relevance, and type of food stimulus) might influence these associations.
Method: Database searches followed the guidelines set by the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA). We included empirical studies that measured both dietary restraint and ABs, excluding studies involving participants with clinical diagnoses or below 16 years of age. Fifty-one eligible articles were identified, of which 29 unique samples were included in the final analyses. The protocol for this meta-analysis was preregistered at: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=532562.
Results: We first examined associations between dietary restraint and attentional maintenance and orienting, separately. This was followed by subgroup analyses to examine whether these associations varied based on the chosen methodological factors. Our findings revealed significant associations between dietary restraint and attentional maintenance in studies that used response tasks (other than the dot probe task), and where the food stimuli were relevant to the task instructions.
Discussion: Collectively,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.